GENERIC MEDICINES REGULATION IN BRAZIL

Journal Title: International Journal of Drug Regulatory Affairs - Year 2017, Vol 5, Issue 3

Abstract

The regulation of medicines in Brazil has proven to be one of the major concerns of government policies in recent decades. In order to improve access to quality medicines for the population, the National Drug Policy was instituted, culminating in the creation of the National Health Surveillance Agency (ANVISA) and the implementation of generic medicines policy. The generic medicines was effectively introduced in Brazil with the publication of the Law nÂș 9.787 in 1999, resulting from an objective of the Ministry of Health to significantly reduce the costs of pharmacological therapy, stimulate commercial competition and facilitate the population's access to drug treatment. In the same year the resolution no 391/1999 regarding the technical requirements for the registration of generics in Brazil was published. Since 1999, several legislation has been published in order to regulate the generic policy in Brazil. The present article summarises the legal framework for the implementation of the generic medicines in Brazil. It also describes the current technical requirements and legislation for the registration and maintenance of the register of generics in Brazil, according to ANVISA.

Authors and Affiliations

Priscila Aburachid Cardoso

Keywords

Related Articles

CONCEPT OF 505 (b) (2) APPLICATION: BENEFITS AND CHALLENGES

A 505(b) (2) application is a new drug application (NDA) delineated in section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act.505(b)(2) application is one that one or a lot of the investigations relied upon by the...

FORMULATION AND IN-VITRO EVALUATION OF HOLLOW MICROSPHERES OF GLIPIZIDE

Present work involves attempts to improve floating time of glipizide by formulation of hollow microspheres incorporating Glyceryl Monostearate and acryflow. The floating microspheres were evaluated for percentage yield,...

Drug approval process in India and Europe

Every time a new drug is developed it requires a great amount of research work in manufacturing, Pre- clinical Science, Controls, Chemistry & Clinical trials. Regulatory agencies have Drug Reviewers who has the responsib...

Regulatory requirements for preparation of Dossier for registration of Pharmaceutical products in ACTD & CTD format

To prepare and compile the Dossier required for Registration of Pharmaceutical Products as per the requirements of each countries which shall be acceptable internationally to develop one regulatory approach. To avoid var...

TECHNOLOGY DVELOPMENT FOR POLYMER MODIFICATION TO ENHANCE SOLUBILITY OF POORLY SOLUBLE DRUG

Solubilization of poorly soluble drugs is a frequently encountered challenge in screening studies of new chemical entities as well as in formulation design and development. Solubility of some drugs is very less; these dr...

Download PDF file
  • EP ID EP326741
  • DOI 10.22270/ijdra.v5i3.201
  • Views 74
  • Downloads 0

How To Cite

Priscila Aburachid Cardoso (2017). GENERIC MEDICINES REGULATION IN BRAZIL. International Journal of Drug Regulatory Affairs, 5(3), 1-9. https://europub.co.uk/articles/-A-326741